Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech

Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among...

from NDTV News - Topstories https://ift.tt/3HTxies
https://ift.tt/eA8V8J